2002•BloodRequires access

Variable patterns of response to rituximab treatment in adults with chronic idiopathic thrombocytopenic purpura

Roberto Stasi, Elisa Stipa, Vittorio Forte, Paola Meo, Sergio Amadori

Abstract

In a recent issue of Blood we reported that rituximab anti-CD20 monoclonal antibody is an active drug in adults with chronic idiopathic thrombocytopenic purpura (ITP), that it is able to induce long-lasting responses, and that in all responders a rise of the platelet count occurs early during

About this research paper

What this paper is about

Why it matters

OpenAlex reports 120 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Rituximab, Medicine, Thrombocytopenic purpura, CD20, Immunology, Platelet, Monoclonal, Monoclonal antibody